Search Results - "Peñate Medina, O."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Stability and CMC determinations of amphiphilic (DSPEPEG(3400)-CTT2) peptide constructs by microtensiometry by Haikola, M., Hirvonen, J., Penate Medina, O., Simpura, I., Kairemo, K., Peltonen, L.

    “…Controlled formation and stability of micelles and micellar properties are crucial in ensuring pharmaceutical and physiological efficiency of drug…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Fluorine-Iabeled Dasatinib Nanoformulations as Targeted Molecular Imaging Probes in a PDGFB-driven Murine Glioblastoma Model by Benezra, M, Hambardzumyan, D, Penate-Medina, O, Veach, DR, Pillarsetty, N, Smith-Jones, P, Philips, E, Ozawa, T, Zanzonko, P B, Longo, V, Holland, E C, Larson, S M, Bradbury, MS

    Published in Neoplasia (New York, N.Y.) (01-12-2012)
    “…Dasatinib, a new-generation Src and platelet-derived growth factor receptor (PDGFR) inhibitor, is currently under evaluation in high-grade glioma clinical…”
    Get full text
    Journal Article
  6. 6

    Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro by MEDINA, Oula Penate, SÖDERLUND, Tim, LAAKKONEN, Liisa J, TUOMINEN, Esa K. J, KOIVUNEN, Erkki, KINNUNEN, Paavo K. J

    Published in Cancer research (Chicago, Ill.) (15-05-2001)
    “…We have recently described a novel cyclic peptide inhibitor CTTHWGFTLC (CTT) for matrix metalloproteinases (MMP)-2 and MMP-9, also called type IV collagenases…”
    Get full text
    Journal Article
  7. 7